Fluoroestradiol (FES) Positron Emission Tomography (PET) Reveals Differences In Pharmacodynamics Of Aromatase Inhibitors, Tamoxifen, And Fulvestrant In Patients With Metastatic Breast Cancer

Những quyển sách tương tự

• Factors influencing the uptake of (18)F-Fluoroestradiol (FES) in patients with estrogen receptor positive (ER+) breast cancer
  Bằng: Peterson, Lanell M, et al.
  Được phát hành: (2011)
• Temporal Heterogeneity of Estrogen Receptor Expression in Bone-Dominant Breast Cancer: (18)F-Fluoroestradiol PET Imaging Shows Return of ER Expression
  Bằng: Currin, Erin, et al.
  Được phát hành: (2016)
• Between-Patient and Within-Patient (Site-to-Site) Variability in Estrogen Receptor Binding, Measured In Vivo by (18)F-Fluoroestradiol PET
  Bằng: Kurland, Brenda F., et al.
  Được phát hành: (2011)
• Estrogen receptor binding (FES PET) and glycolytic activity (FDG PET) predict progression-free survival on endocrine therapy in patients with ER+ breast cancer
  Bằng: Kurland, Brenda F., et al.
  Được phát hành: (2016)
• Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients
  Bằng: Kurland, Brenda F, et al.
  Được phát hành: (2012)